Skip to main content
Log in

High-intensity focused ultrasound ablation: a non-surgical approach to treat advanced and complicated liver alveococcosis

  • Case Report
  • Published:
Journal of Medical Ultrasonics Aims and scope Submit manuscript

Abstract

Liver alveococcosis is a life-threatening parasitic disease with progressive growth and wide metastasis to neighboring tissues, lungs, and brain. The radical treatment option is surgery along with a few chemical therapies. However, the frequency of progression and recurrence, as well as postoperative complications and mortality, remains very high. The high-intensity focused ultrasound (HIFU) treatment system, a therapeutic application using ultrasound to deliver heat or agitation into the body, was initially designed to treat cancer. Advanced and complicated forms of liver alveococcosis usually require surgical treatment to provide partial ectomy of necrotized liver tissue along with alveococcal caverns and sanitation of the peritoneal cavity. In this article, we presented a case of successful HIFU ablation with transhepatic puncture and drainage in treatment of complicated and advanced liver alveococcosis to avoid wide surgical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Deplazes P, Eckert J. Diagnosis of the Echinococcus multilocularis infection in final hosts. Appl Parasitol. 1996;37:245–52.

    PubMed  CAS  Google Scholar 

  2. Vuitton D, Meslin F, Eckert J, et al. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull World Health Organ. 1996;74:231–42.

    Google Scholar 

  3. Ammann R. Clinical diagnosis and treatment of echinococcosis in humans. In: Thompson RCA, Lymbery AJ, editors. Echinococcus and hydatid disease. Oxfordshire: CAB International Wallingford; 1995. p. 411–63.

    Google Scholar 

  4. Imankulov S, Baigenzhin A, Tuganbekov T, et al. Hydatid echinococcosis—a modern view. J Clin Med Kaz. 2015;2:11–4.

    Google Scholar 

  5. Bakhtiyarov A, Utepbergenova G, Sagitova S. Echinococcosis of rare localizations. J Clin Med Kaz. 2016;1:47–9.

    Article  Google Scholar 

  6. Ibragimov A, Matkasimova Z, Raeva J, et al. Ultrasonic diagnosis of right ventricle hydatid cysts: report of a rare case. J Clin Med Kaz. 2014;1:48–51.

    Google Scholar 

  7. Schantz PM, Chai J, Craig PS, et al. Epidemiology and control of hydatid disease. In: Thompson RCA, Lymbery AJ, editors. Echinococcus and hydatid disease. CAB International: Wallingford; 1995. p. 233–333.

    Google Scholar 

  8. Buttenschoen K, Gruener B, Carli Buttenschoen D, et al. Palliative operation for the treatment of alveolar echinococcosis. Langenbecks Arch Surg. 2009;394:199–204.

    Article  PubMed  Google Scholar 

  9. Artemyev A, Naydenov E, Zabezhinsky D, et al. Liver transplantation for unresectable hepatic alveolar echinococcosis. Mod Technol Med. 2017;9:123–127.

    Google Scholar 

  10. Patkowski W, Kotulski M, Remiszewski P, et al. Alveococcosis of the liver—strategy of surgical treatment with special focus on liver transplantation. Transpl Infect Dis. 2016;18:661–6.

    Article  PubMed  CAS  Google Scholar 

  11. Jun-jie C, Monhebat M. Analysis of recurrent cases with hepatic cystic echinococcosis treated by emulsion albendazole. Endemic Dis Bull (China). 2001;3:032.

    Google Scholar 

  12. Shikhman S. Analysis of mortality after surgery for alveococcosis of the liver. Vestnik khirurgii imeni II Grekova. 1982;129:32–7.

    CAS  Google Scholar 

  13. Kawamura N, Kamiyama T, Sato N, et al. Long-term results of hepatectomy for patients with alveolar echinococcosis: a single-center experience. J Am Coll Surg. 2011;212:804–12.

    Article  PubMed  Google Scholar 

  14. Hsiao YH, Kuo SJ, Tsai HD, et al. Clinical application of high-intensity focused ultrasound in cancer therapy. J Cancer. 2016;7:225–31.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Imankulov SB, Fedotovskikh GV, Zhampeissov NK, et al. Treatment of liver alveococcosis with high-intensity focused ultrasound. Ultrason Sonochem. 2015;27:707–11.

    Article  PubMed  CAS  Google Scholar 

  16. Imankulov SB, Fedotovskikh GV, Shaimardanova GM, et al. Feasibility study of high intensity focused ultrasound (HIFU) for the treatment of hydatid cysts of the liver. Ultrason Sonochem. 2015;27:712–6.

    Article  PubMed  CAS  Google Scholar 

  17. Brunetti E, Kern P, Vuitton DA, et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114:1–16.

    Article  PubMed  Google Scholar 

  18. Ishizu H, Uchino J, Sato N, et al. Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery. Hepatology. 1997;25:528–31.

    Article  PubMed  CAS  Google Scholar 

  19. Kern P, Bardonnet K, Renner E, et al. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis. 2003;9:343–9.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tamarozzi F, Vuitton L, Brunetti E, et al. Non-surgical and non-chemical attempts to treat echinococcosis: do they work? Parasite. 2014;21:75.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Cai H, Chen LL, Ye B, et al. The destructive effects of high-intensity focused ultrasound on hydatid cysts enhanced by ultrasound contrast agent and superabsorbent polymer alone or in combination. Parasitol Res. 2013;112:707–17.

    Article  PubMed  Google Scholar 

  22. Zou X, Wang J, Zhao H, et al. Echinococcus granulosus: protoscolicidal effect of high intensity focused ultrasound. Exp Parasitol. 2009;121:312–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abduzhappar Gaipov.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Ethical statements

The Institutional Ethics Committee approved application of HIFU ablation in treatment of liver alveococcosis. Additional informed consent was obtained from the patient for which identifying information is included in this article.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhampeissov, N., Manap, E., Rustemova, K. et al. High-intensity focused ultrasound ablation: a non-surgical approach to treat advanced and complicated liver alveococcosis. J Med Ultrasonics 46, 251–255 (2019). https://doi.org/10.1007/s10396-018-0914-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10396-018-0914-x

Keywords

Navigation